Structure |
Chemical Name |
CAS |
MF |
 |
Canagliflozin Impurity 22 |
|
|
 |
Carfilzomib Impurity 3 |
|
|
 |
Dolutegravir Impurity 4 |
|
|
 |
Febuxostat Impurity 20 |
|
|
 |
Lenvatinib Impurity 1 |
|
|
![methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20211123/GIF/83508-82-1.gif) |
methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
83508-82-1 |
C21H26N2O3 |
![4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester](/CAS/20180703/GIF/1941177-45-2.gif) |
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester |
1941177-45-2 |
C29H37N7O3 |
 |
Cabozantinib impurity 1 |
748707-58-6 |
C17H16N2O3 |
 |
Amlodipine Impurity 19 |
|
C26H31ClN2O8S |
 |
Amlodipine Impurity 9 |
90445-05-9 |
C26H31ClN2O8S |
 |
Clopidogrel Impurity 7 |
444728-13-6 |
C15H15ClN2OS |
 |
Rivaroxaban Impurity 36 |
1770812-39-9 |
C19H17Cl2N3O5S |
 |
(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
1111177-24-2 |
C20H23N5O2 |
 |
Clopidogrel Impurity C |
1346605-15-9 |
C16H18ClNO2S |
 |
Nilotinib genotoxic impurity 2 |
1157857-29-8 |
C19H15F3N4O3 |
![N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン](/CAS/20180808/GIF/1453221-45-8.gif) |
N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン |
1453221-45-8 |
C35H41F6N3O6 |
 |
Gliclazide Impurity E |
|
|
 |
Ethyl 1-butanesulfonate |
2374-68-7 |
C6H14O3S |
 |
Isavuconazole Impurity 48 |
|
|
 |
5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-hydroxyquinolin-2(1H)-one) |
|
|
![2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid](/CAS/20181212/GIF/CB39996369.gif) |
2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid |
|
C27H35N3O3 |
 |
Tafluprost Impurity 19 |
|
|
![(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/769908-13-6.gif) |
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
769908-13-6 |
C25H24FNO4 |
![(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate](/CAS/20180808/GIF/261506-24-5.gif) |
(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
261506-24-5 |
C34H49F5O4S |
![1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid](/CAS2/GIF/1163685-30-0.gif) |
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
1163685-30-0 |
C14H11N3O3 |
 |
O-Desethyl Candesartan Cilexetil |
869631-11-8 |
C31H30N6O6 |
 |
Epi Lovastatin |
79952-44-6 |
C24H36O5 |
 |
Hydroxy Brimonidine |
1216379-05-3 |
C11H12BrN5O |
 |
7-メトキシ-3,4-ジヒドロキノリン-2(1H)-オン |
22246-17-9 |
C10H11NO2 |
 |
N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩 |
1049695-95-5 |
C17H21NO.HCl |
 |
モンテルカストメチルケトン |
937275-23-5 |
C34H32ClNO3S |
 |
Propyl Itraconazole |
74855-91-7 |
C34H36Cl2N8O4 |
 |
3-methyleneisobenzofuran-1(3H)-one |
3453-63-2 |
C9H6O2 |
 |
OLANEXIDINE intermediate |
60852-95-1 |
C10H20N4 |
 |
1H-Isoindole, octahydro-, trans- |
10479-63-7 |
C8H15N |
![1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI)](/CAS/20180601/GIF/155272-03-0.gif) |
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |
155272-03-0 |
C18H20N4O4 |
 |
Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
181289-34-9 |
C9H17NO3 |
![4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate](/CAS/20180601/GIF/65141-48-2.gif) |
4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate |
65141-48-2 |
C8H10N4O7 |
 |
2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE |
91219-90-8 |
C11H15NO3 |
 |
4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE |
112809-52-6 |
C17H11N5 |
 |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
 |
Tadalafil EP impurity E |
|
|
![4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine](/CAS/20200611/GIF/134965-85-8.gif) |
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine |
134965-85-8 |
C12H7ClN6 |
 |
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
 |
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
1388858-78-3 |
C19H23FN2O2 |
![1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one](/CAS/20200401/GIF/220182-11-6.gif) |
1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one |
220182-11-6 |
C10H20N4O |
 |
Ropivacaine EP Impurity D |
98626-59-6 |
C16H24N2O |
 |
Bendamustine Impurity 16 |
914626-65-6 |
C19H18N6O4 |
 |
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
959392-22-4 |
C18H19NOS |
 |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
 |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
 |
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
![3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン](/CAS/GIF/54528-00-6.gif) |
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
 |
Tafluprost Impurity 17 |
|
|
![(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB32735563.gif) |
(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C14H20ClN5O4S |
 |
Posaconazole iMpurity 5 |
|
|
 |
Topiroxostat Impurity 5 |
1199273-82-9 |
C14H7N7 |
 |
N-Ethoxycarbonyl Ciprofloxacin |
93594-29-7 |
C20H22FN3O5 |
 |
Norepinephrine Tartrate Impurity G |
13062-58-3 |
C22H21NO3 |
 |
Vortioxetine Impurity 1 |
1293489-71-0 |
C17H20N2S |
 |
4-bromo-2-nitropyridine |
909712-10-3 |
C5H3BrN2O2 |
 |
1,3-Bis(1H-1,2,4-triazol-1-yl)-2-propanone |
98414-56-3 |
C7H8N6O |
 |
Rosuvastatin Impurity 162 |
|
|
 |
Rosuvastatin Impurity 151 |
|
|
 |
Rosuvastatin Impurity 148 |
|
|
 |
フロセミドアシルグルクロニド |
72967-59-0 |
C18H19ClN2O11S |
 |
Digoxin Impurity 1 |
|
|
 |
Bimatoprost Impurity 23 |
|
|
 |
Irbesartan impurity A |
|
C25H28N6O |
![(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine](/CAS/20180713/GIF/223673-35-6.gif) |
(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine |
223673-35-6 |
C21H26N2O5 |
 |
Azelastine N-Oxide |
640279-88-5 |
C22H24ClN3O2 |
![4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド](/CAS/GIF/1193725-75-5.gif) |
4-(8-クロロ-6,11-ジヒドロ-5H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-イル)-3-ピリジノール1-オキシド |
1193725-75-5 |
C19H15ClN2O2 |
 |
16α,17,21-Trihydroxy-pregna-1,4-diene-3,11,20-trione |
3754-05-0 |
C21H26O6 |
![4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity](/CAS/GIF/116182-43-5.gif) |
4H-Furo[2,3-c]pyranyl Mupirocin SodiuM IMpurity |
116182-43-5 |
C26H43NaO9 |
 |
N-(3-エチニル-4-メチルフェニル)-6,7-ビス(2-メトキシエトキシ)キナゾリン-4-アミン |
1346601-52-2 |
C23H25N3O4 |
![5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン](/CAS/GIF/951624-49-0.gif) |
5-[[(4-フルオロフェニル)メチル]アミノ]-1,3-ジヒドロ-2H-イミダゾ[4,5-B]ピリジン-2-オン |
951624-49-0 |
C13H11FN4O |
 |
ペリンドプリラットラクタムB |
130061-28-8 |
C17H26N2O4 |
 |
シュードモン酸Dナトリウム |
85178-60-5 |
C26H41NaO9 |
 |
N-DesMethyl SuMatriptan |
88919-51-1 |
C13H19N3O2S |
 |
2-epi-(-)-EMtricitabine |
145416-34-8 |
C8H10FN3O3S |
 |
Parent nucleus of cefotiaM hydrochloride |
372092-19-8 |
C13H21N7O3S2 |
![Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/20150408/GIF/111664-35-8.gif) |
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
111664-35-8 |
C22H19NO4 |
 |
6-(2,5-dichlorophenyl)-1,3,5-Triazine-2,4(1H,3H)-dione |
30222-00-5 |
C9H5Cl2N3O2 |
 |
ウリジン, 2'-デオキシ-2'-フルオロ-2'-メチル-, '3',5'-二安息香酸, (2'R)- |
863329-65-1 |
C24H21FN2O7 |
 |
Celecoxib iMpurity-A |
|
|
 |
EMtricitabine iMpurity A |
|
|
 |
RocuroniuMbroMide iMpurity D |
|
|
 |
(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride |
220548-73-2 |
C12H17ClFNO |
 |
LaMotrigine IMpurity D |
661463-79-2 |
C9H5Cl2N3O2 |
 |
デメチルピペラジニルデスエチルシルデナフィルスルホニルクロリド |
139756-27-7 |
C15H15ClN4O4S |
 |
Rizatriptan IMpurity B |
1016900-28-9 |
C13H15ClN5 |
 |
rac Adrenaline IMpurity D |
1095714-91-2 |
C16H19NO3 |
 |
2-イソプロペニル-6-イソプロピルフェノール |
74926-89-9 |
C12H16O |
 |
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
![(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one](/) |
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
 |
(3R)-3α,4α-(1,3-ジベンジルウレイレン)テトラヒドロチオフェン-5-オン |
28092-52-6 |
C19H18N2O2S |
 |
(2S)-2-ピロリジンカルボン酸メチル |
2577-48-2 |
C6H11NO2 |
 |
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
 |
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |